To Investigate Safety, Reactogenicity and Immunogenicity of VIR-1388 Compared With Placebo in Participants Without HIV

NCT05854381 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

93

Enrollment

NIH

Sponsor class

Conditions

HIV I Infection

Interventions

BIOLOGICAL: VIR-1388
BIOLOGICAL: Placebo

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)

Collaborators

[object Object]